Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2023-09-12 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
第四届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution from the first meeting of the fourth supervisory board of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the meeting's convening, attendance, and the election of the supervisory board chairman. It references compliance with company law and stock exchange listing rules, and mentions a related announcement about board and senior management changes. The document is not a financial report, audit, or earnings release, nor is it a call transcript or investor presentation. It is clearly an announcement about changes in the company's supervisory board leadership, which falls under Board/Management Information (MANG). The document length is short and focused on governance changes, not a full report or presentation.
2023-09-12 Chinese
独立董事关于第四届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on the appointment of senior management positions including general manager, deputy general manager, financial director, and board secretary. It discusses the compliance of the appointment procedures with company law and stock exchange listing rules, and confirms the qualifications of the appointees. There is no financial data, earnings information, or report publication mentioned. The content is about management appointments and related board matters. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or certification, so it is not RPA or RNS.
2023-09-12 Chinese
第四届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the first meeting of the fourth board of directors of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the election and appointment of key board and senior management personnel, including the chairman, general manager, deputy general manager, financial director, and board secretary. The document includes meeting attendance, voting results, and compliance with relevant laws and company regulations. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in the company's board and senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 3328 characters, which is consistent with a detailed announcement rather than a brief notice or report publication announcement.
2023-09-12 Chinese
投资者关系活动记录表
Interim / Quarterly Report Classification · 95% confidence The document is titled as an "投资者关系活动记录表" (Investor Relations Activity Record) and specifically mentions it is a "2023年半年度报告业绩说明会" (2023 Half-Year Report Earnings Explanation Meeting). The content includes detailed Q&A about the company's half-year performance, business strategy, market conditions, and future outlook. It is described as an "业绩说明会" (earnings explanation meeting), which is typically a detailed discussion of interim or quarterly results. The document length is 3310 characters, which is relatively short but contains substantive content about the half-year financial performance and business operations, not just an announcement or a link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR) because it contains substantive financial data and analysis for a period shorter than a full fiscal year. It is not a simple announcement or a transcript of a call but a detailed investor presentation of half-year results. Hence, the best classification is IR with high confidence. H1 2023
2023-09-05 Chinese
投资者关系活动记录表
Call Transcript Classification · 90% confidence The document is titled as an "投资者关系活动记录表" (Investor Relations Activity Record) and specifically mentions it is a "2023年半年度报告业绩说明会" (2023 Half-Year Report Earnings Explanation Meeting). The content includes detailed Q&A about the company's half-year performance, business strategy, market conditions, and outlook, which is typical of an earnings conference call or earnings presentation. The document length is 3310 characters, which is relatively short and does not contain full financial statements or detailed financial data, but rather a summary and discussion of the half-year results. It is not a full interim report (IR) because it lacks substantive financial data and statements. It is also not a simple announcement or publication notice. The document is a transcript or record of an earnings explanation meeting, which aligns best with the category "Call Transcript (CT)" as it captures the Q&A and management discussion during the earnings call. Therefore, the most appropriate classification is CT with high confidence.
2023-09-05 Chinese
2023年半年度报告业绩说明会预告公告
Call Transcript Classification · 70% confidence The document is a short announcement (1039 characters) about a scheduled earnings performance explanation meeting related to the company's 2023 half-year report. It references the half-year report already published on August 24, 2023, and invites investors to participate in a webcast on September 5, 2023. The document does not contain actual financial data or detailed financial statements but serves as a notice for an upcoming earnings call event. According to the rules, such announcements about earnings explanation meetings are classified as Call Transcript (CT) if they contain the transcript, but this document is only a notice of the meeting, not the transcript itself. It is not an Interim/Quarterly Report (IR) because it lacks substantive financial data. It is also not a Report Publication Announcement (RPA) because it is about a meeting, not the report publication itself. The best fit is Call Transcript (CT) category as it relates to an earnings performance explanation meeting, even though it is a notice rather than the transcript, this is the closest category given the options. Confidence is moderate due to the document being a meeting notice rather than a full transcript.
2023-08-30 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.